Literature DB >> 18069774

Prolonged cholestasis following successful removal of common bile duct stones: beware patients on estrogen therapy.

J M Dunn1, A McNair.   

Abstract

There are various well described forms of chronic cholestatic jaundice in adults, such as autoimmune cholangitis, drug-induced cholangitis and intrahepatic cholestasis of pregnancy. We present two cases of prolonged cholestasis following removal of gallstones at endoscopic retrograde cholangiopancreatography (ERCP) and subsequent clear cholangiography. Both patients were taking oral estrogens at the time of presentation, which were subsequently withdrawn. The first case responded rapidly to corticosteroid treatment, and the second case had a much slower resolution with ursodeoxycholic acid. Both cases highlighted the significance of estrogen-induced cholestasis in female patients with protracted jaundice following ERCP and removal of intra-ductal stones. After oral estrogens are discontinued, a short course of steroids needs to be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18069774      PMCID: PMC4171244          DOI: 10.3748/wjg.v13.i46.6277

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

1.  Prolonged cholestatic jaundice after endoscopic retrograde cholangiography.

Authors:  S P Dourakis; C Mayroyannis; A Alexopoulou; S J Hadziyannis
Journal:  Hepatogastroenterology       Date:  1997 May-Jun

2.  Jaundice associated with norethindrone acetate therapy.

Authors:  R A PEREZ-MERA; C E SHIELDS
Journal:  N Engl J Med       Date:  1962-11-29       Impact factor: 91.245

3.  Protracted cholestasis probably induced by oral contraceptive.

Authors:  M Wedén; H Glaumann; K Einarsson
Journal:  J Intern Med       Date:  1992-05       Impact factor: 8.989

4.  Effect of estrogen therapy on gallbladder disease.

Authors:  Dominic J Cirillo; Robert B Wallace; Rebecca J Rodabough; Philip Greenland; Andrea Z LaCroix; Marian C Limacher; Joseph C Larson
Journal:  JAMA       Date:  2005-01-19       Impact factor: 56.272

Review 5.  Physical and metabolic factors in gallstone pathogenesis.

Authors:  J M Donovan
Journal:  Gastroenterol Clin North Am       Date:  1999-03       Impact factor: 3.806

6.  Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.

Authors:  Anna Glantz; Hanns-Ulrich Marschall; Frank Lammert; Lars-Ake Mattsson
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

7.  Cholestatic syndromes.

Authors:  Michael Trauner; James L Boyer
Journal:  Curr Opin Gastroenterol       Date:  2004-05       Impact factor: 3.287

Review 8.  Intrahepatic cholestasis of pregnancy: an estrogen-related disease.

Authors:  H Reyes; F R Simon
Journal:  Semin Liver Dis       Date:  1993-08       Impact factor: 6.115

9.  Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat.

Authors:  M Meyers; W Slikker; G Pascoe; M Vore
Journal:  J Pharmacol Exp Ther       Date:  1980-07       Impact factor: 4.030

10.  Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis.

Authors:  Dumont Micheline; Jacquemin Emmanuel; Erlinger Serge
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-08       Impact factor: 2.839

View more
  1 in total

1.  Glucocorticoids Cause Gender-Dependent Reversal of Hepatic Fibrosis in the MDR2-Knockout Mouse Model.

Authors:  Anca D Petrescu; Stephanie Grant; Gabriel Frampton; Jessica Kain; Karam Hadidi; Elaina Williams; Matthew McMillin; Sharon DeMorrow
Journal:  Int J Mol Sci       Date:  2017-11-10       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.